Franklin

Hatch-Waxman Act [electronic resource] : Proposed Legislative Changes Affecting Pharmaceutical Patents.

Author/Creator:
Library of Congress. Congressional Research Service.
Publication:
[S.l] : [publisher not identified], 2003.
Format/Description:
Government document
Book
1 online resource (12 pages) : digital, PDF file
Status/Location:
Loading...

Options
Location Notes Your Loan Policy

Details

Subjects:
Drugs.
Medical laws and legislation.
Patents.
System Details:
System requirements: PDF reader software.
Summary:
Reviews proposed legislative changes to the Drug Price Competition and Patent Term Restoration Act of 1984, known as the Hatch-Waxman Act, which revised patent laws as applied to pharmaceutical products. Discusses general provisions of the law, selected patent-related issues, FTC report on abbreviated new drug applications, proposed FDA rule change regarding requirements for listing pharmaceutical patents in the Orange Book, and various legislative proposals in the 108th Congress to amend the Hatch-Waxman Act.
Notes:
CRS Report.
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC.
Other format:
Microfiche version: Library of Congress. Congressional Research Service. Hatch-Waxman Act
Access Restriction:
Restricted for use by site license.